Description
The global molecular point of care testing (using NAAT) market is expected to grow due to improving healthcare facilities and infrastructures and the adoption of end-of-care testing at the hospital, laboratories, and clinics, which can drive the market's growth. The other factors anticipated to propel the development of the molecular point of care testing (using NAAT) market include the rising prevalence of infectious diseases. The other factors, such as the lack of skilled professionals and the high cost of customized molecular point-of-care testing (using NAAT), hamper the growth of the global molecular end-of-care testing (using NAAT) market. On the other hand, the increased healthcare expenditure and emerging countries with developed hospitals act as an opportunity to grow the global molecular point of care testing (using NAAT) market. molecular point of care testing (using NAAT) market is expected to reach USD 62,553.67 million by 2029 , from USD 25,170.05 million in 2020, growing at the CAGR of 10.8% in the forecast period of 2021 to 2029 .
Sample Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=-molecular-point-of-care-testing-using-naat-market
Molecular Point of Care Testing (using NAAT) Market Analysis and Insights
These instruments are essentially used in molecularly detecting various disorders such as HIV, HPV, and respiratory disease through NAAT technology. NAAT is Nucleic Acid Amplification Techniques that allow the identification of pathogenic organisms by detecting their DNA or RNA. The leading MOLECULAR POINT OF CARE TESTING (USING NAAT) market report eases the process of acquiring valuable market insights with the new skills, latest tools and innovative programs, which is sure to aid in achieving business goals. POCT is characterized as testing which can be done close to the patient where a medical decision can be made immediately, including the results and monitoring. POCT devices now entering clinical use are based on nucleic acid amplification technologies (NAAT), defined here as second-generation devices. These platforms generally have improved sensitivity, typically 60 to 90%, compared to first-generation POCTs, and require portable instrumentation with a footprint of approximately 30cm x 30cm.
Access Full Report:- https://www.databridgemarketresearch.com/reports/-molecular-point-of-care-testing-using-naat-market
Molecular Point Of Care Testing (Using NAAT) Market Scope And Market Size
With the increase in the successful diagnosis of chronic diseases, including cancer, anemia, type 2 diabetes, and others, the improved health care professionals provide regular training sessions for the professionals for conducting tests in account for the improvement of diagnosis rate in the region. With the increase in the burden of diseases, the diagnosis rate is also increasing. With the advancements in the diagnosis, the rate is also growing for people going through the diagnosis.
- On the basis of product, the molecular point of care testing (using NAAT) market is segmented into instruments, consumables, and reagents. In 2021, the consumables & reagents segment in the molecular point of care testing (using NAAT) market is expected to grow due to changing lifestyles and increasing chronic diseases, and increasing awareness of over-the-counter NAAT-based POCT devices.
- On the basis of end user, the molecular point of care testing (using NAAT) market is segmented into laboratories, hospitals, clinics, ambulatory centres, home care, assisted living facilities, and others. In 2021, the laboratories segment in the molecular point of care testing (using NAAT) market is expected to dominate because of the high preference of POCT testing being recommended to laboratories as they are fully focused on the diagnosis of the various disorder.
- On the basis of distribution channel, the molecular point of care testing (using NAAT) market is segmented into direct tender, third party distributor, online sales. In 2021, the direct sales segment in the molecular point of care testing (using NAAT) market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.
Get TOC of the Report: https://www.databridgemarketresearch.com/toc/?dbmr=-molecular-point-of-care-testing-using-naat-market
Major TOC of the Molecular Point Of Care Testing (Using NAAT) Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Molecular Point Of Care Testing (Using NAAT) Market Country Level Analysis
Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Molecular Point Of Care Testing (Using NAAT) Market Share Analysis
Point-of-care testing devices are beneficial for detecting various diseases and supporting treatment plans using POC software and solutions. Healthcare spending comprises out-of-pocket payments (people paying for their care), government expenditure, and sources including health insurance and activities by non-governmental organizations. Increasing healthcare expenditure and infrastructure can help patients take hassle-free advanced treatment to receive better diagnoses, procedures, and treatment for fast recovery. U.S. is expected to dominate the molecular point of care testing (using NAAT) market because of the increasing diagnosis rate and awareness about chronic disease. U.K. is expected to molecular point of care testing (using NAAT) market due to increased procurement of advanced technologies available for molecular POCT. India in South Asia region is expected to molecular point of care testing (using NAAT) market due to the presence of huge potential for procurement of product and rising healthcare.
Some of the major companies providing molecular point of care testing (using NAAT) products in the molecular point of care testing (using NAAT) market are
- Thermo Fisher Scientific Inc.,
- Hologic, Inc.,
- BD, F. Hoffmann-La Roche Ltd,
- binx health, inc.,
- Sysmex (A Subsidiary of Sysmex Corporation),
- Co-Diagnostics, Inc.,
- ABBOTT, Seegene Inc.,
- bioMérieux SA,
- QIAGEN,
- Bio-Rad Laboratories, Inc.,
- PerkinElmer Inc.,
- Grifols,
- A.,
- Quidel Corporation,
- GenMark Diagnostics, Inc.,
- SD Biosensor, INC.,
- Oxford Nanopore Technologies,
- Wondfo,
- Randox Laboratories Ltd.,
- Meridian Bioscience,
- Sekisui Diagnostics,
- QuantuMDx Group Ltd.,
- Lucira Health Inc.,
- Danaher,
Browse Related Reports @
Asia-Pacific Single Use Medical Devices Reprocessing Market
Middle East and Africa Single Use Medical Devices Reprocessing Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
